Market Overview

Avadel Pharmaceuticals Lowers FY17 Sales From $170-$185M To $165-$175M, Adj. EPS Unchanged At $0.30-$0.45 vs $0.54 Est.

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: Guidance

 

Related Articles (AVDL)